Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma.

Shaikh, Faiq; Chan, Aubrey C; Awan, Omer; Jerath, Nivedita; Reddy, Chandan; Khan, Salman A; Graham, Michael M

Shaikh, Faiq; Chan, Aubrey C; Awan, Omer; Jerath, Nivedita; Reddy, Chandan; Khan, Salman A; Graham, Michael M.

Afiliação

Shaikh F; Imaging Informatics, University of Pittsburgh Medical Center ; Molecular Imaging Physician, S&L Readings, LLC. ; CEO, Crunchtimr Medical Solutions, LLC.
Chan AC; Department of Internal Medicine, University of Iowa Hospitals and Clinics.
Awan O; Department of Radiology, Dartmouth Hitchcock Medical Center.
Jerath N; Department of Neurology, University of Iowa Hospitals and Clinics.
Reddy C; Department of Neurosurgery, University of Iowa Hospitals and Clinics.
Khan SA; Department of Internal Medicine, University of Missouri Kansas City.
Graham MM; Department of Radiology, University of Iowa Hospitals and Clinics.

Cureus ; 7(9): e319, 2015 Sep 09.

Article em En | MEDLINE | ID: mdl-26487995

Palavras-chave

csf cytology; diffuse large b-cell lymphoma (dlbcl); fdg; mri; neurolymphomatosis; non-hodgkin's lymphoma; pet-ct

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Revista: Cureus Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google